Combination therapy with SGLT2 inhibitor and beta-blocker in patients with HFpEF and atrial fibrillation: impact on nt-proBNP, HS-CRP, e/e′ and functional capacity
Event:
CBCS Summer School 2025
Topic:
Heart Failure
Session:
Poster rapid fire session